Medical Properties Trust, Inc. (MPT) Institutional Ownership & Insider Trading

488 institutions reported holding Medical Properties Trust, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 1 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

MPTMedical Properties Trust, Inc.Follow MPT — free

REIT - Healthcare Facilities · Real Estate

—

Price chart with a free account

Market cap: 1.6B
P/E TTM: —
Dividend yield: 13.0%
52-week: —
Next earnings: 29 Oct, in 5 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

488 institutions held 61.1% of the shares. Across filers that reported both quarters, shares held changed +5.7%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	488	365	+5.7%	158	39	150	38
Mar 26	485	345	+0.7%	154	52	139	48
Dec 25	475	345	+2.7%	140	54	135	46
Sep 25	447	337	-3.4%	132	45	157	55
Jun 25	463	346	-1.7%	120	42	167	42
Mar 25	458	351	-3.6%	132	53	143	49
Dec 24	456	364	-5.0%	102	32	183	81
Sep 24	494	380	-3.3%	125	49	181	40

Medical Properties Trust, Inc. — questions

Who owns Medical Properties Trust, Inc. stock?: 488 institutions reported Medical Properties Trust, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (12.6%), VANGUARD PORTFOLIO MANAGEMENT LLC (7.3%), STATE STREET CORP (4.2%).
Are Medical Properties Trust, Inc. insiders buying or selling?: 1 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Medical Properties Trust, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.